Medical Devices & Consumables

Global Arteriosclerosis Therapeutics Market Insights, Forecast to 2030

Arteriosclerosis is a generalized thickening and stiffening of the arterial wall and is related to high blood pressure or hypertension.
Market Analysis and Insights: Global Arteriosclerosis Therapeutics Market
The global Arteriosclerosis Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Arteriosclerosis Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Arteriosclerosis Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Arteriosclerosis Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Arteriosclerosis Therapeutics include AstraZeneca, Pfizer, Bayer, Merck, Novartis, Sanofi, Hoffmann-La Roche, GlaxoSmithKline and Isis Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Arteriosclerosis Therapeutics is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Arteriosclerosis Therapeutics industry development. In 2023, global % revenue of Arteriosclerosis Therapeutics went into Hospital filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Arteriosclerosis Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Arteriosclerosis Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Arteriosclerosis Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Arteriosclerosis Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Arteriosclerosis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Arteriosclerosis Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
AstraZeneca
Pfizer
Bayer
Merck
Novartis
Sanofi
Hoffmann-La Roche
GlaxoSmithKline
Isis Pharmaceuticals
Anthera Pharmaceuticals
Johnson and Johnson
Cardium Therapeutics
Segment by Type
Medicine
Surgery
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Arteriosclerosis Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Arteriosclerosis Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Arteriosclerosis Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Arteriosclerosis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Medicine
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Arteriosclerosis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Arteriosclerosis Therapeutics Market Perspective (2019-2030)
2.2 Global Arteriosclerosis Therapeutics Growth Trends by Region
2.2.1 Arteriosclerosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Arteriosclerosis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Arteriosclerosis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Arteriosclerosis Therapeutics Market Dynamics
2.3.1 Arteriosclerosis Therapeutics Industry Trends
2.3.2 Arteriosclerosis Therapeutics Market Drivers
2.3.3 Arteriosclerosis Therapeutics Market Challenges
2.3.4 Arteriosclerosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Arteriosclerosis Therapeutics by Players
3.1.1 Global Arteriosclerosis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Arteriosclerosis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Arteriosclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Arteriosclerosis Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Arteriosclerosis Therapeutics Market Concentration Ratio
3.4.1 Global Arteriosclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Arteriosclerosis Therapeutics Revenue in 2023
3.5 Global Key Players of Arteriosclerosis Therapeutics Head office and Area Served
3.6 Global Key Players of Arteriosclerosis Therapeutics, Product and Application
3.7 Global Key Players of Arteriosclerosis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Arteriosclerosis Therapeutics Breakdown Data by Type
4.1 Global Arteriosclerosis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Arteriosclerosis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Arteriosclerosis Therapeutics Breakdown Data by Application
5.1 Global Arteriosclerosis Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Arteriosclerosis Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Arteriosclerosis Therapeutics Market Size (2019-2030)
6.2 North America Arteriosclerosis Therapeutics Market Size by Type
6.2.1 North America Arteriosclerosis Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Arteriosclerosis Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Arteriosclerosis Therapeutics Market Share by Type (2019-2030)
6.3 North America Arteriosclerosis Therapeutics Market Size by Application
6.3.1 North America Arteriosclerosis Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Arteriosclerosis Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Arteriosclerosis Therapeutics Market Share by Application (2019-2030)
6.4 North America Arteriosclerosis Therapeutics Market Size by Country
6.4.1 North America Arteriosclerosis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Arteriosclerosis Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Arteriosclerosis Therapeutics Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Arteriosclerosis Therapeutics Market Size (2019-2030)
7.2 Europe Arteriosclerosis Therapeutics Market Size by Type
7.2.1 Europe Arteriosclerosis Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Arteriosclerosis Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Arteriosclerosis Therapeutics Market Share by Type (2019-2030)
7.3 Europe Arteriosclerosis Therapeutics Market Size by Application
7.3.1 Europe Arteriosclerosis Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Arteriosclerosis Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Arteriosclerosis Therapeutics Market Share by Application (2019-2030)
7.4 Europe Arteriosclerosis Therapeutics Market Size by Country
7.4.1 Europe Arteriosclerosis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Arteriosclerosis Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Arteriosclerosis Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Arteriosclerosis Therapeutics Market Size (2019-2030)
8.2 China Arteriosclerosis Therapeutics Market Size by Type
8.2.1 China Arteriosclerosis Therapeutics Market Size by Type (2019-2024)
8.2.2 China Arteriosclerosis Therapeutics Market Size by Type (2025-2030)
8.2.3 China Arteriosclerosis Therapeutics Market Share by Type (2019-2030)
8.3 China Arteriosclerosis Therapeutics Market Size by Application
8.3.1 China Arteriosclerosis Therapeutics Market Size by Application (2019-2024)
8.3.2 China Arteriosclerosis Therapeutics Market Size by Application (2025-2030)
8.3.3 China Arteriosclerosis Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Arteriosclerosis Therapeutics Market Size (2019-2030)
9.2 Asia Arteriosclerosis Therapeutics Market Size by Type
9.2.1 Asia Arteriosclerosis Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Arteriosclerosis Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Arteriosclerosis Therapeutics Market Share by Type (2019-2030)
9.3 Asia Arteriosclerosis Therapeutics Market Size by Application
9.3.1 Asia Arteriosclerosis Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Arteriosclerosis Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Arteriosclerosis Therapeutics Market Share by Application (2019-2030)
9.4 Asia Arteriosclerosis Therapeutics Market Size by Region
9.4.1 Asia Arteriosclerosis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Arteriosclerosis Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Arteriosclerosis Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Arteriosclerosis Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.1.5 AstraZeneca Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Arteriosclerosis Therapeutics Introduction
11.2.4 Pfizer Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Arteriosclerosis Therapeutics Introduction
11.3.4 Bayer Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.3.5 Bayer Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Arteriosclerosis Therapeutics Introduction
11.4.4 Merck Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.4.5 Merck Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Arteriosclerosis Therapeutics Introduction
11.5.4 Novartis Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.5.5 Novartis Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Arteriosclerosis Therapeutics Introduction
11.6.4 Sanofi Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.6.5 Sanofi Recent Developments
11.7 Hoffmann-La Roche
11.7.1 Hoffmann-La Roche Company Details
11.7.2 Hoffmann-La Roche Business Overview
11.7.3 Hoffmann-La Roche Arteriosclerosis Therapeutics Introduction
11.7.4 Hoffmann-La Roche Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.7.5 Hoffmann-La Roche Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Arteriosclerosis Therapeutics Introduction
11.8.4 GlaxoSmithKline Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Developments
11.9 Isis Pharmaceuticals
11.9.1 Isis Pharmaceuticals Company Details
11.9.2 Isis Pharmaceuticals Business Overview
11.9.3 Isis Pharmaceuticals Arteriosclerosis Therapeutics Introduction
11.9.4 Isis Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.9.5 Isis Pharmaceuticals Recent Developments
11.10 Anthera Pharmaceuticals
11.10.1 Anthera Pharmaceuticals Company Details
11.10.2 Anthera Pharmaceuticals Business Overview
11.10.3 Anthera Pharmaceuticals Arteriosclerosis Therapeutics Introduction
11.10.4 Anthera Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.10.5 Anthera Pharmaceuticals Recent Developments
11.11 Johnson and Johnson
11.11.1 Johnson and Johnson Company Details
11.11.2 Johnson and Johnson Business Overview
11.11.3 Johnson and Johnson Arteriosclerosis Therapeutics Introduction
11.11.4 Johnson and Johnson Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.11.5 Johnson and Johnson Recent Developments
11.12 Cardium Therapeutics
11.12.1 Cardium Therapeutics Company Details
11.12.2 Cardium Therapeutics Business Overview
11.12.3 Cardium Therapeutics Arteriosclerosis Therapeutics Introduction
11.12.4 Cardium Therapeutics Revenue in Arteriosclerosis Therapeutics Business (2019-2024)
11.12.5 Cardium Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Arteriosclerosis Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Global Arteriosclerosis Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Arteriosclerosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Arteriosclerosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Arteriosclerosis Therapeutics Market Share by Region (2019-2024)
Table 8. Global Arteriosclerosis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Arteriosclerosis Therapeutics Market Share by Region (2025-2030)
Table 10. Arteriosclerosis Therapeutics Market Trends
Table 11. Arteriosclerosis Therapeutics Market Drivers
Table 12. Arteriosclerosis Therapeutics Market Challenges
Table 13. Arteriosclerosis Therapeutics Market Restraints
Table 14. Global Arteriosclerosis Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Arteriosclerosis Therapeutics Revenue Share by Players (2019-2024)
Table 16. Global Top Arteriosclerosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arteriosclerosis Therapeutics as of 2023)
Table 17. Global Arteriosclerosis Therapeutics Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Arteriosclerosis Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Arteriosclerosis Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Arteriosclerosis Therapeutics, Product and Application
Table 21. Global Key Players of Arteriosclerosis Therapeutics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Arteriosclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Arteriosclerosis Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Arteriosclerosis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Arteriosclerosis Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Arteriosclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Arteriosclerosis Therapeutics Revenue Share by Application (2019-2024)
Table 29. Global Arteriosclerosis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Arteriosclerosis Therapeutics Revenue Share by Application (2025-2030)
Table 31. North America Arteriosclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Arteriosclerosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Arteriosclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Arteriosclerosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Arteriosclerosis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Arteriosclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Arteriosclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Arteriosclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Arteriosclerosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Arteriosclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Arteriosclerosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Arteriosclerosis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Arteriosclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Arteriosclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Arteriosclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Arteriosclerosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Arteriosclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Arteriosclerosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Arteriosclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Arteriosclerosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Arteriosclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Arteriosclerosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Arteriosclerosis Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Arteriosclerosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Arteriosclerosis Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Arteriosclerosis Therapeutics Product
Table 66. AstraZeneca Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 67. AstraZeneca Recent Developments
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Arteriosclerosis Therapeutics Product
Table 71. Pfizer Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 72. Pfizer Recent Developments
Table 73. Bayer Company Details
Table 74. Bayer Business Overview
Table 75. Bayer Arteriosclerosis Therapeutics Product
Table 76. Bayer Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 77. Bayer Recent Developments
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Arteriosclerosis Therapeutics Product
Table 81. Merck Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 82. Merck Recent Developments
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Arteriosclerosis Therapeutics Product
Table 86. Novartis Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 87. Novartis Recent Developments
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Arteriosclerosis Therapeutics Product
Table 91. Sanofi Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 92. Sanofi Recent Developments
Table 93. Hoffmann-La Roche Company Details
Table 94. Hoffmann-La Roche Business Overview
Table 95. Hoffmann-La Roche Arteriosclerosis Therapeutics Product
Table 96. Hoffmann-La Roche Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 97. Hoffmann-La Roche Recent Developments
Table 98. GlaxoSmithKline Company Details
Table 99. GlaxoSmithKline Business Overview
Table 100. GlaxoSmithKline Arteriosclerosis Therapeutics Product
Table 101. GlaxoSmithKline Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 102. GlaxoSmithKline Recent Developments
Table 103. Isis Pharmaceuticals Company Details
Table 104. Isis Pharmaceuticals Business Overview
Table 105. Isis Pharmaceuticals Arteriosclerosis Therapeutics Product
Table 106. Isis Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 107. Isis Pharmaceuticals Recent Developments
Table 108. Anthera Pharmaceuticals Company Details
Table 109. Anthera Pharmaceuticals Business Overview
Table 110. Anthera Pharmaceuticals Arteriosclerosis Therapeutics Product
Table 111. Anthera Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 112. Anthera Pharmaceuticals Recent Developments
Table 113. Johnson and Johnson Company Details
Table 114. Johnson and Johnson Business Overview
Table 115. Johnson and Johnson Arteriosclerosis Therapeutics Product
Table 116. Johnson and Johnson Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 117. Johnson and Johnson Recent Developments
Table 118. Cardium Therapeutics Company Details
Table 119. Cardium Therapeutics Business Overview
Table 120. Cardium Therapeutics Arteriosclerosis Therapeutics Product
Table 121. Cardium Therapeutics Revenue in Arteriosclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 122. Cardium Therapeutics Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Arteriosclerosis Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Arteriosclerosis Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Medicine Features
Figure 4. Surgery Features
Figure 5. Global Arteriosclerosis Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Arteriosclerosis Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Arteriosclerosis Therapeutics Report Years Considered
Figure 11. Global Arteriosclerosis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Arteriosclerosis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Arteriosclerosis Therapeutics Market Share by Region: 2023 VS 2030
Figure 14. Global Arteriosclerosis Therapeutics Market Share by Players in 2023
Figure 15. Global Top Arteriosclerosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arteriosclerosis Therapeutics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Arteriosclerosis Therapeutics Revenue in 2023
Figure 17. North America Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Arteriosclerosis Therapeutics Market Share by Type (2019-2030)
Figure 19. North America Arteriosclerosis Therapeutics Market Share by Application (2019-2030)
Figure 20. North America Arteriosclerosis Therapeutics Market Share by Country (2019-2030)
Figure 21. United States Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Arteriosclerosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe Arteriosclerosis Therapeutics Market Share by Type (2019-2030)
Figure 25. Europe Arteriosclerosis Therapeutics Market Share by Application (2019-2030)
Figure 26. Europe Arteriosclerosis Therapeutics Market Share by Country (2019-2030)
Figure 27. Germany Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China Arteriosclerosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China Arteriosclerosis Therapeutics Market Share by Type (2019-2030)
Figure 35. China Arteriosclerosis Therapeutics Market Share by Application (2019-2030)
Figure 36. Asia Arteriosclerosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia Arteriosclerosis Therapeutics Market Share by Type (2019-2030)
Figure 38. Asia Arteriosclerosis Therapeutics Market Share by Application (2019-2030)
Figure 39. Asia Arteriosclerosis Therapeutics Market Share by Region (2019-2030)
Figure 40. Japan Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America Arteriosclerosis Therapeutics Market Share by Country (2019-2030)
Figure 50. Brazil Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries Arteriosclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. AstraZeneca Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 57. Pfizer Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 58. Bayer Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 59. Merck Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 60. Novartis Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 61. Sanofi Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 62. Hoffmann-La Roche Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 64. Isis Pharmaceuticals Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 65. Anthera Pharmaceuticals Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 66. Johnson and Johnson Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 67. Cardium Therapeutics Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies